(-)-Epigallocatechin-3-gallate inhibits invasion and migration of salivary gland adenocarcinoma cells

Oncology Reports

Volumn 23, Issue 2, 2010, Pages 585-590

  Park, Jong Hwan ^a   Yoon, J I Hye ^a   Kim, Soo A ^b   Ahn, Sang Gun ^a   Yoon, Jung Hoon ^a  

^a Chosun University   (South Korea)

^b Dongguk University   (South Korea)

Author keywords

1 integrin; ( ) Epigallocatechin 3 gallate; Invasion; Migration; Salivary gland tumor

Indexed keywords

BETA1 INTEGRIN; EPIGALLOCATECHIN GALLATE; FOCAL ADHESION KINASE; GELATIN; GELATINASE A; GELATINASE B; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B;

APOPTOSIS; ARTICLE; CELL INVASION; CELL MIGRATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SALIVARY GLAND CARCINOMA; SIGNAL TRANSDUCTION; WOUND; ZYMOGRAPHY;

ADENOCARCINOMA; ANTICARCINOGENIC AGENTS; ANTIGENS, CD29; CATECHIN; CELL ADHESION; CELL MOVEMENT; CELL SURVIVAL; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; SALIVARY GLAND NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 76649100163     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00000673     Document Type: Article

References (44)

1. Etges A, Nunes FD, Ribeiro KC and Araujo VC: Immunohistochemical expression of retinoblastoma pathway proteins in normal salivary glands and in salivary gland tumours. Oral Oncol 40: 326-331, 2004.
2. Milano A, Longo F, Basile M, Iaffaioli RV and Caponigro F: Recent advances in the treatment of salivary gland cancers: emphasis on molecular targeted therapy. Oral Oncol 43: 729-734, 2007.
3. Prenen H, Kimpe M and Nuyts S: Salivary gland carcinomas: molecular abnormalities as potential therapeutic targets. Curr Opin Oncol 20: 270-274, 2008.
4. Spitz MR, Tilley BC, Batsakis JG, Gibeau JM and Newell GR: Risk factors for major salivary gland carcinoma. A casecomparison study. Cancer 54: 1854-1859, 1984.
5. Preston-Martin S, Thomas DC, White SC and Cohen D: Prior exposure to medical and dental x-rays related to tumors of the parotid gland. J Natl Cancer Inst 80: 943-949, 1988.
6. Maxon HR, Saenger EL, Buncher CR, et al: Radiation-associated carcinoma of the salivary glands. A controlled study. Ann Otol Rhinol Laryngol 90: 107-108, 1981.
7. Hsu YC, Lu HF, Huang CC, Hsu RF and Su CY: Malignant lymphoepithelial lesions of the salivary gland. Otolaryngol Head Neck Surg 134: 661-666, 2006.
8. Barnes L, Everson JW and Reichart P: World Health Organization classification of tumours. IARC Press, Lyon, 2005.
9. Spiro RH: Management of malignant tumors of the salivary glands. Oncology (Williston Park) 12: 671-683, 1998.
10. Dodd RL and Slevin NJ: Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies. Oral Oncol 42: 759-769, 2006.
11. Graham HN: Green tea composition, consumption and polyphenol chemistry. Prev Med 21: 334-350, 1992.
12. Yang GY, Liao J, Kim K, Yurkow EJ and Yang CS: Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 19: 611-616, 1998.
13. Jung YD, Kim MS, Shin BA, et al: EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Br J Cancer 84: 844-850, 2001.
14. Lim YC, Park HY, Hwang HS, et al: (-)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells. Cancer Lett 271: 140-152, 2008.
15. Ho YC, Yang SF, Peng CY, Chou MY and Chang YC: Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator. J Oral Pathol Med 36: 588-593, 2007.
16. Kato K, Long NK, Makita H, et al: Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. Br J Cancer 99: 647-654, 2008.
17. Kushima Y, Iida K, Nagaoka Y, et al: Inhibitory effect of (-)-epigallocatechin and (-)-epigallocatechin gallate against heregulin beta1-induced migration/invasion of the MCF-7 breast carcinoma cell line. Biol Pharm Bull 32: 899-904, 2009.
18. Ishino A, Kusama K, Watanabe S and Sakagami H: Inhibition of epigallocatechin gallate-induced apoptosis by CoCl2 in human oral tumor cell lines. Anticancer Res 19: 5197-5201, 1999.
19. Kusama K, Jiang Y, Toguchi M, et al: Use of the monoclonal antibody M30 for detecting HSG cell apoptosis. Anticancer Res 20: 151-154, 2000.
20. Shrestha P, Sumitomo S, Lee CH, et al: Tenascin: growth and adhesion modulation-extracellular matrix degrading function: an in vitro study. Eur J Cancer B Oral Oncol 32B: 106-113, 1996.
21. Lin TH, Kuo HC, Chou FP and Lu FJ: Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide. BMC Cancer 8: 58, 2008.
22. Lee KJ, Hwang SJ, Choi JH and Jeong HG: Saponins derived from the roots of Platycodon grandiflorum inhibit HT-1080 cell invasion and MMPs activities: regulation of NF-kappaB activation via ROS signal pathway. Cancer Lett 268: 233-243, 2008.
23. Bergers G and Benjamin LE: Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3: 401-410, 2003.
24. Kalluri R: Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3: 422-433, 2003.
25. Jin H and Varner J: Integrins: roles in cancer development and as treatment targets. Br J Cancer 90: 561-565, 2004.
26. Sounni NE and Noel A: Membrane type-matrix metalloproteinases and tumor progression. Biochimie 87: 329-342, 2005.
27. Khan N and Mukhtar H: Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett 269: 269-280, 2008.
28. Hung CF, Huang TF, Chiang HS and Wu WB: (-)-Epigallocatechin-3-gallate, a polyphenolic compound from green tea, inhibits fibroblast adhesion and migration through multiple mechanisms. J Cell Biochem 96: 183-197, 2005.
29. Arvelo F and Cotte C: Metalloproteinases in tumor progression. (Review). Invest Clin 47: 185-205, 2006.
30. Pasco S, Brassart B, Ramont L, Maquart FX and Monboisse JC: Control of melanoma cell invasion by type IV collagen. Cancer Detect Prev 29: 260-266, 2005.
31. Hynes RO: Integrins: bidirectional, allosteric signaling machines. Cell 110: 673-687, 2002.
32. Hemler ME, Mannion BA and Berditchevski F: Association of TM4SF proteins with integrins: relevance to cancer. Biochim Biophys Acta 1287: 67-71, 1996.
33. Morini M, Mottolese M, Ferrari N, et al: The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int J Cancer 87: 336-342, 2000.
34. Varner JA and Cheresh DA: Integrins and cancer. Curr Opin Cell Biol 8: 724-730, 1996.
35. Miranti CK and Brugge JS: Sensing the environment: a historical perspective on integrin signal transduction. Nat Cell Biol 4: E83-E90, 2002.
36. Sonoda Y, Watanabe S, Matsumoto Y, Aizu-Yokota E and Kasahara T: FAK is the upstream signal protein of the phosphatidylinositol 3-kinase-Akt survival pathway in hydrogen peroxide-induced apoptosis of a human glioblastoma cell line. J Biol Chem 274: 10566-10570, 1999.
37. Schlaepfer DD and Hunter T: Focal adhesion kinase overexpression enhances ras-dependent integrin signaling to ERK2/ mitogen-activated protein kinase through interactions with and activation of c-Src. J Biol Chem 272: 13189-13195, 1997.
38. Sankar S, Mahooti-Brooks N, Hu G and Madri JA: Modulation of cell spreading and migration by pp125FAK phosphorylation. Am J Pathol 147: 601-608, 1995.
39. Somanath PR, Kandel ES, Hay N and Byzova TV: Akt1 signaling regulates integrin activation, matrix recognition, and fibronectin assembly. J Biol Chem 282: 22964-22976, 2007.
40. Irie HY, Pearline RV, Grueneberg D, et al: Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelialmesenchymal transition. J Cell Biol 171: 1023-1034, 2005.
41. John A and Tuszynski G: The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 7: 14-23, 2001.
42. Johnson LL, Dyer R and Hupe DJ: Matrix metalloproteinases. Curr Opin Chem Biol 2: 466-471, 1998.
43. Westermarck J and Kahari VM: Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13: 781-792, 1999.
44. Garbisa S, Sartor L, Biggin S, Salvato B, Benelli R and Albini A: Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer 91: 822-832, 2001.